Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.34M Hold
27,798
1.83% 10
2025
Q4
$2.93M Buy
+27,798
New +$2.61M 1.59% 12
2024
Q4
Sell
-9,473
Closed -$1.08M 173
2024
Q3
$1.08M Sell
9,473
-734
-7% -$87.2K 0.8% 39
2024
Q2
$1.26M Sell
10,207
-5,267
-34% -$678K 0.99% 29
2024
Q1
$2.04M Sell
15,474
-4,930
-24% -$608K 1.19% 18
2023
Q4
$2.22M Sell
20,404
-647
-3% -$67.2K 1.54% 12
2023
Q3
$2.17M Buy
21,051
+961
+5% +$104K 1.62% 11
2023
Q2
$2.32M Sell
20,090
-553
-3% -$62.8K 1.86% 9
2023
Q1
$2.2M Buy
+20,643
New +$2.23M 2.07% 8
2021
Q2
Sell
-15,007
Closed -$1.1M 138
2021
Q1
$1.1M Sell
15,007
-1,717
-10% -$127K 0.83% 48
2020
Q4
$1.3M Buy
16,724
+3,506
+27% +$268K 1.01% 40
2020
Q3
$1.05M Sell
13,218
-7,199
-35% -$564K 1.3% 31
2020
Q2
$1.51M Sell
20,417
-1,239
-6% -$93.3K 1.71% 18
2020
Q1
$1.59M Sell
21,656
-1,010
-4% -$79.4K 3.81% 9
2019
Q4
$1.97M Sell
22,666
-1,075
-5% -$88.3K 1.93% 18
2019
Q3
$1.91M Sell
23,741
-8,856
-27% -$710K 1.9% 19
2019
Q2
$2.61M Buy
+32,597
New +$2.5M 1.95% 20
2018
Q4
Sell
-44,886
Closed -$3.04M 151
2018
Q3
$3.04M Buy
44,886
+14,799
+49% +$943K 1.77% 10
2018
Q2
$1.74M Buy
+30,087
New +$1.7M 1.8% 19
2016
Q3
Sell
-13,098
Closed -$720K 118
2016
Q2
$720K Buy
13,098
+1,829
+16% +$97.3K 0.74% 51
2016
Q1
$569K Buy
+11,269
New +$552K 0.71% 60

Other funds holding MRK

WESPAC Advisors's MRK Position: Q1 2026 in Review

WESPAC Advisors held its Merck (MRK) position steady in Q1 2026 at 27,798 shares worth $3.34M. The position accounts for 1.83% of the portfolio, ranked #10.

WESPAC Advisors first reported a position in MRK in Q1 2016 and has held it in 21 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WESPAC Advisors held 27,798 shares of Merck worth $3.34M as of Q1 2026.
  • WESPAC Advisors left its Merck share count unchanged in Q1 2026.
  • Merck made up 1.83% of WESPAC Advisors's portfolio in Q1 2026, its #10 holding.
  • WESPAC Advisors first reported a position in Merck in Q1 2016 and has held it in 21 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WESPAC Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.